Huntington's disease transgenic mice are resistant to global cerebral ischemia

Neuroscience Letters

Volumn 334, Issue 2, 2002, Pages 99-102

  Schiefer, Johannes ^a   Alberty, Anke ^a   Dose, Tatjana ^a   Oliva, Sabine ^a   Noth, Johannes ^a   Kosinski, Christoph M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Excitotoxicity; Hippocampus; Huntington's disease; Ischemia; Ischemic tolerance; Preconditioning; R6 1 mice

Indexed keywords

CYCLOHEXIMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; EXON; GENE EXPRESSION; HIPPOCAMPUS; HUNTINGTON CHOREA; HYPOXEMIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; TRANSGENIC MOUSE;

ANIMALS; CYCLOHEXIMIDE; EXONS; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; HUNTINGTON DISEASE; IMMUNITY, NATURAL; ISCHEMIC ATTACK, TRANSIENT; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS;

EID: 0037073566     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01111-4     Document Type: Article

References (20)

1. Barone F.C., White R.F., Spera P.A., Ellison J., Currie R.W., Wang X., Feuerstein G.Z. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 29:1998;1937-1950. discussion 1950-1951.
2. Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1991;1649-1659.
3. Berry K., Wisniewski H.M., Svarzbein L., Baez S. On the relationship of brain vasculature to production of neurological deficit and morphological changes following acute unilateral common carotid artery ligation in gerbils. J. Neurol. Sci. 25:1975;75-92.
4. Cepeda C., Ariano M.A., Calvert C.R., Flores-Hernandez J., Chandler S.H., Leavitt B.R., Hayden M.R., Levine M.S. NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res. 66:2001;525-539.
5. Davies S., Beardsall K., Turmaine M., DiFiglia M., Aronin N., Bates G. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet. 351:1998;131-133.
6. Hansson O., Guatteo E., Mercuri N.B., Bernardi G., Li X.J., Castilho R.F., Brundin P. Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioral deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene. Eur. J. Neursci. 14:2001;1492-1504.
7. Hansson O., Petersen A., Leist M., Nicotera P., Castilho R.F., Brundin P. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl. Acad. Sci. USA. 96:1999;8727-8732.
8. Huntington's Disease Collaborative Research Group . A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
9. Icton C., Zeron M., Wellington C., Leavitt B., Hayden M., Raymond L. Probing the interaction between Huntingtin and NMDA receptors. Soc. Neurosci. Abstr. 2000;38217.
10. Laforet G.A., Sapp E., Chase K., McIntyre C., Boyce F.M., Campbell M., Cadigan B.A., Warzecki L., Tagle D.A., Reddy P.H., Cepeda C., Calvert C.R., Jokel E.S., Klapstein G.J., Ariano M.A., Levine M.S., DiFiglia M., Aronin N. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J. Neurosci. 21:2001;9112-9123.
11. Lievens J.C., Woodman B., Mahal A., Spasic-Boscovic O., Samuel D., Kerkerian-Le-Goff L., Bates G.P. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol. Disease. 8:2001;807-821.
12. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S., Bates G. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506.
13. Morton A.J., Leavens W. Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity. Brain Res. Bull. 52:2000;51-59.
14. Schmued L., Hopkins K. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874:2000;123-130.
15. Sharp A.H., Ross C.A. Neurobiology of Huntington's disease. Neurobiol. Disease. 3:1996;3-15.
16. Sheng H., Laskowitz D.T., Mackensen G.B., Kudo M., Pearlstein R.D., Warner D.S. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. Stroke. 30:1999;1118-1124.
17. Sun Y., Savanenin A., Reddy P.H., Liu Y. Polyglutamin-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. J. Biol. Chem. 276:2001;24713-24718.
18. Wellons J.C. 3rd, Sheng H., Laskowitz D.T., Burkhard Mackensen G., Pearlstein R.D., Warner D.S. A comparison of strain-related susceptibility in two murine recovery models of global cerebral ischemia. Brain Res. 868:2000;14-21.
19. Zeron M.M., Chen N., Moshaver A., Ting-Chun Lee A., Wellington C.L., Hayden M.R., Raymond L.A. Mutant Huntingtin Enhances Excitotoxic Cell Death. Mol. Cell Neurosci. 17:2001;41-53.
20. Zeron M.M., Hansson O., Chen N., Wellington C.L., Leavitt B.R., Brundin P., Hayden M.R., Raymond L.A. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron. 33:2002;849-860.